These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 1891714)

  • 41. Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection.
    Kowalik TF; Wing B; Haskill JS; Azizkhan JC; Baldwin AS; Huang ES
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1107-11. PubMed ID: 8381532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.
    Hatada EN; Nieters A; Wulczyn FG; Naumann M; Meyer R; Nucifora G; McKeithan TW; Scheidereit C
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2489-93. PubMed ID: 1532257
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diverse molecular mechanisms of inhibition of NF-kappa B/DNA binding complexes by I kappa B proteins.
    Léveillard T; Verma IM
    Gene Expr; 1993; 3(2):135-50. PubMed ID: 8268718
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
    Carrasco D; Rizzo CA; Dorfman K; Bravo R
    EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kappa B-specific DNA binding proteins are differentially inhibited by enhancer mutations and biological oxidation.
    Molitor JA; Ballard DW; Greene WC
    New Biol; 1991 Oct; 3(10):987-96. PubMed ID: 1768652
    [TBL] [Abstract][Full Text] [Related]  

  • 46. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
    Mosialos G; Gilmore TD
    Oncogene; 1993 Mar; 8(3):721-30. PubMed ID: 8437855
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discreet mutations from c-Rel to v-Rel alter kappaB DNA recognition, IkappaBalpha binding, and dimerization: implications for v-Rel oncogenicity.
    Phelps CB; Ghosh G
    Oncogene; 2004 Feb; 23(6):1229-38. PubMed ID: 14961076
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cloning of a differentially expressed I kappa B-related protein.
    Ray P; Zhang DH; Elias JA; Ray A
    J Biol Chem; 1995 May; 270(18):10680-5. PubMed ID: 7738005
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Repression of the chicken c-rel promoter by vRel in chicken embryo fibroblasts is not mediated through a consensus NF-kappa B binding site.
    Capobianco AJ; Gilmore TD
    Oncogene; 1991 Dec; 6(12):2203-10. PubMed ID: 1766669
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A yeast transcription assay defines distinct rel and dorsal DNA recognition sequences.
    Kamens J; Brent R
    New Biol; 1991 Oct; 3(10):1005-13. PubMed ID: 1768648
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiac myotrophin exhibits rel/NF-kappa B interacting activity in vitro.
    Sivasubramanian N; Adhikary G; Sil PC; Sen S
    J Biol Chem; 1996 Feb; 271(5):2812-6. PubMed ID: 8576259
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cloning of the DNA-binding subunit of human nuclear factor kappa B: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alpha.
    Meyer R; Hatada EN; Hohmann HP; Haiker M; Bartsch C; Röthlisberger U; Lahm HW; Schlaeger EJ; van Loon AP; Scheidereit C
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):966-70. PubMed ID: 1992489
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction of the C-terminal region of p105 with the nuclear localisation signal of p50 is required for inhibition of NF-kappa B DNA binding activity.
    Matthews JR; Watson E; Buckley S; Hay RT
    Nucleic Acids Res; 1993 Sep; 21(19):4516-23. PubMed ID: 7694229
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation.
    Read MA; Whitley MZ; Williams AJ; Collins T
    J Exp Med; 1994 Feb; 179(2):503-12. PubMed ID: 7507507
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
    Cogswell PC; Scheinman RI; Baldwin AS
    J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.
    Verma IM; Stevenson JK; Schwarz EM; Van Antwerp D; Miyamoto S
    Genes Dev; 1995 Nov; 9(22):2723-35. PubMed ID: 7590248
    [No Abstract]   [Full Text] [Related]  

  • 57. Tax protein of HTLV-1 interacts with the Rel homology domain of NF-kappa B p65 and c-Rel proteins bound to the NF-kappa B binding site and activates transcription.
    Suzuki T; Hirai H; Yoshida M
    Oncogene; 1994 Nov; 9(11):3099-105. PubMed ID: 7936632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B.
    Ruben SM; Dillon PJ; Schreck R; Henkel T; Chen CH; Maher M; Baeuerle PA; Rosen CA
    Science; 1991 Mar; 251(5000):1490-3. PubMed ID: 2006423
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10.
    Chang CC; Zhang J; Lombardi L; Neri A; Dalla-Favera R
    Oncogene; 1994 Mar; 9(3):923-33. PubMed ID: 8108136
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rel/NF-kappa B/I kappa B story.
    Miyamoto S; Verma IM
    Adv Cancer Res; 1995; 66():255-92. PubMed ID: 7793317
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.